These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7912081)

  • 1. Human hematolymphoid cells in SCID mice.
    Kaneshima H; Namikawa R; McCune JM
    Curr Opin Immunol; 1994 Apr; 6(2):327-33. PubMed ID: 7912081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis.
    McCune J; Kaneshima H; Krowka J; Namikawa R; Outzen H; Peault B; Rabin L; Shih CC; Yee E; Lieberman M
    Annu Rev Immunol; 1991; 9():399-429. PubMed ID: 1910684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human peripheral blood leukocyte-reconstituted severe combined immunodeficient mouse: analysis of the human immune response against porcine islet transplantation.
    Shiroki R; Naziruddin B; Shishido S; Duffy BF; Howard T; Mohanakumar T
    Transplantation; 1997 Mar; 63(6):818-23. PubMed ID: 9089220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and applications of the SCID-hu mouse model.
    McCune JM
    Semin Immunol; 1996 Aug; 8(4):187-96. PubMed ID: 8883141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SCID-hu mouse: a small animal model for the analysis of human hematolymphoid differentiation and function.
    McCune JM
    Bone Marrow Transplant; 1992; 9 Suppl 1():74-6. PubMed ID: 1354528
    [No Abstract]   [Full Text] [Related]  

  • 7. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
    Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
    Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS.
    Jamieson BD; Aldrovandi GM; Zack JA
    Semin Immunol; 1996 Aug; 8(4):215-21. PubMed ID: 8883144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized SCID mouse models for biomedical research.
    Pearson T; Greiner DL; Shultz LD
    Curr Top Microbiol Immunol; 2008; 324():25-51. PubMed ID: 18481451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.
    Shultz LD; Lang PA; Christianson SW; Gott B; Lyons B; Umeda S; Leiter E; Hesselton R; Wagar EJ; Leif JH; Kollet O; Lapidot T; Greiner DL
    J Immunol; 2000 Mar; 164(5):2496-507. PubMed ID: 10679087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
    Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
    J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of human lymphocyte-engrafted SCID mice as a model for immunotoxicity assessment.
    Pollock PL; Germolec DR; Comment CE; Rosenthal GJ; Luster MI
    Fundam Appl Toxicol; 1994 Jan; 22(1):130-8. PubMed ID: 8125206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenogeneic PBL-scid mice: their potential and current limitations.
    Greenwood JD
    Lab Anim Sci; 1993 Apr; 43(2):151-5. PubMed ID: 8320963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral pathogenesis in hu-PBL-SCID mice.
    Mosier DE
    Semin Immunol; 1996 Aug; 8(4):255-62. PubMed ID: 8883149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCID mice as an in vivo model of human cord blood hematopoiesis.
    Vormoor J; Lapidot T; Pflumio F; Risdon G; Patterson B; Broxmeyer HE; Dick JE
    Blood Cells; 1994; 20(2-3):316-20; discussion 320-2. PubMed ID: 7538337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of SCID mice with human lymphoid and myeloid cells after transplantation with human fetal bone marrow without the requirement for exogenous human cytokines.
    Kollmann TR; Kim A; Zhuang X; Hachamovitch M; Goldstein H
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8032-6. PubMed ID: 7914701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCID mouse models of human stem cell engraftment.
    Greiner DL; Hesselton RA; Shultz LD
    Stem Cells; 1998; 16(3):166-77. PubMed ID: 9617892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of human peripheral blood lymphocytes after transplantation into SCID mice.
    Martino G; Anastasi J; Feng J; Mc Shan C; DeGroot L; Quintans J; Grimaldi LM
    Eur J Immunol; 1993 May; 23(5):1023-8. PubMed ID: 8477797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans.
    Saxon A; Macy E; Denis K; Tary-Lehmann M; Witte O; Braun J
    J Clin Invest; 1991 Feb; 87(2):658-65. PubMed ID: 1991850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras.
    Tary-Lehmann M; Lehmann PV; Schols D; Roncarolo MG; Saxon A
    J Exp Med; 1994 Nov; 180(5):1817-27. PubMed ID: 7964463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.